CYTO Annual Current Liabilities
$1.06 M
-$12.83 M-92.38%
01 December 2023
Summary:
As of January 23, 2025, CYTO annual total current liabilities is $1.06 million, with the most recent change of -$12.83 million (-92.38%) on December 1, 2023. During the last 3 years, it has fallen by -$2.41 million (-69.48%). CYTO annual current liabilities is now -94.33% below its all-time high of $18.66 million, reached on December 31, 2013.CYTO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Quarterly Current Liabilities
$1.23 M
+$534.10 K+76.98%
01 June 2024
Summary:
As of January 23, 2025, CYTO quarterly total current liabilities is $1.23 million, with the most recent change of +$534.10 thousand (+76.98%) on June 1, 2024. Over the past year, it has dropped by -$4.74 million (-79.43%). CYTO quarterly current liabilities is now -93.42% below its all-time high of $18.66 million, reached on December 31, 2013.CYTO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -92.4% | -79.4% |
| 3 y3 years | -69.5% | -91.2% |
| 5 y5 years | -77.2% | -91.2% |
CYTO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.4% | at low | -91.2% | +77.0% |
| 5 y | 5-year | -92.4% | at low | -91.2% | +77.0% |
| alltime | all time | -94.3% | +39.6% | -93.4% | +77.0% |
Altamira Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $1.23 M(+77.0%) |
| Dec 2023 | $1.06 M(-92.4%) | $693.80 K(-88.4%) |
| June 2023 | - | $5.97 M(-57.0%) |
| Dec 2022 | $13.89 M(+161.3%) | $13.89 M(+35.4%) |
| June 2022 | - | $10.26 M(+92.9%) |
| Dec 2021 | $5.32 M(+53.3%) | $5.32 M(+59.5%) |
| June 2021 | - | $3.33 M(-3.9%) |
| Dec 2020 | $3.47 M(+47.5%) | $3.47 M(+36.2%) |
| June 2020 | - | $2.55 M(+8.3%) |
| Dec 2019 | $2.35 M(-49.3%) | $2.35 M(+28.8%) |
| June 2019 | - | $1.83 M(-60.6%) |
| Dec 2018 | $4.63 M(-56.7%) | $4.63 M(-32.2%) |
| Sept 2018 | - | $6.83 M(-27.9%) |
| June 2018 | - | $9.47 M(-8.4%) |
| Mar 2018 | - | $10.35 M(-3.3%) |
| Dec 2017 | $10.70 M | $10.70 M(-7.6%) |
| Sept 2017 | - | $11.58 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $11.09 M(+5.7%) |
| Mar 2017 | - | $10.49 M(+19.3%) |
| Dec 2016 | $8.80 M(+41.1%) | $8.79 M(+2.7%) |
| Sept 2016 | - | $8.56 M(+34.7%) |
| June 2016 | - | $6.36 M(+5.6%) |
| Mar 2016 | - | $6.02 M(-3.5%) |
| Dec 2015 | $6.24 M(+39.0%) | $6.24 M(+1.6%) |
| Sept 2015 | - | $6.14 M(-7.4%) |
| June 2015 | - | $6.63 M(+28.4%) |
| Mar 2015 | - | $5.17 M(+15.1%) |
| Dec 2014 | $4.49 M(-75.9%) | $4.49 M(-25.8%) |
| Sept 2014 | - | $6.05 M(+102.0%) |
| June 2014 | - | $3.00 M(-19.8%) |
| Mar 2014 | - | $3.73 M(-80.0%) |
| Dec 2013 | $18.66 M(+1864.7%) | $18.66 M |
| Dec 2012 | $949.90 K(+25.3%) | - |
| Dec 2011 | $758.30 K | - |
FAQ
- What is Altamira Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Altamira Therapeutics?
- What is Altamira Therapeutics annual current liabilities year-on-year change?
- What is Altamira Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly current liabilities year-on-year change?
What is Altamira Therapeutics annual total current liabilities?
The current annual current liabilities of CYTO is $1.06 M
What is the all time high annual current liabilities for Altamira Therapeutics?
Altamira Therapeutics all-time high annual total current liabilities is $18.66 M
What is Altamira Therapeutics annual current liabilities year-on-year change?
Over the past year, CYTO annual total current liabilities has changed by -$12.83 M (-92.38%)
What is Altamira Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CYTO is $1.23 M
What is the all time high quarterly current liabilities for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly total current liabilities is $18.66 M
What is Altamira Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CYTO quarterly total current liabilities has changed by -$4.74 M (-79.43%)